PR NEWSWIRE (EN) Sisram Medical Reports Completion of NIFDC Testing for DAXXIFY in China 5 Januari 2026, 9:36 am
PR NEWSWIRE (EN) Kelun-Biotech Announces Breakthrough Therapy Designation Granted in China for Sacituzumab Tirumotecan (sac-TMT) in Combination with Immunotherapy Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC 5 Januari 2026, 9:29 am
PR NEWSWIRE (EN) Patriot Memory Showcases Next-Generation Performance at CES 2026 5 Januari 2026, 8:45 am
